NSCLC, RECURRENT
Clinical trials for NSCLC, RECURRENT explained in plain language.
Never miss a new study
Get alerted when new NSCLC, RECURRENT trials appear
Sign up with your email to follow new studies for NSCLC, RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Smart immune cells take aim at Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, called CAR T cells, that are specially designed to target and kill solid tumor cells while leaving healthy cells unharmed. It is for adults with certain advanced cancers, including lung, colon, pancreatic, ovari…
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New combo aims to outsmart resistant lung cancer
Disease control Recruiting nowThis study tests whether adding pirfenidone to the immunotherapy drug atezolizumab can help shrink tumors and prevent treatment resistance in people with advanced or returning non-small cell lung cancer. About 25 adults with stage IV or recurrent NSCLC who have already tried at l…
Matched conditions: NSCLC, RECURRENT
Phase: PHASE1, PHASE2 • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC